Showing results (11-20 of 83) with videos related to
Sort By:
Pageof 9
Cell Chemical Biology|July 16, 2026
Emerging challenges, mechanisms, and therapeutic opportunities in cell deathScott J Dixon, Guido Kroemer, Guillaume Lessene, et al.The Journal of Organic Chemistry|August 29, 2009
Characterization of the two fundamental conformations of benzoylureas and elucidation of the factors that facilitate their conformational interchangeGuillaume Lessene, Brian J Smith, Robert W Gable, et al.The Journal of Organic Chemistry|July 14, 2018
Strategies, Setbacks, and Successes in the Synthesis of (-)-SpiroleucettadineRichard A Lamb, Nigel T Lucas, Guillaume Lessene, et al.Combinatorial Chemistry & High Throughput Screening|January 14, 2014
A perspective on 10-years HTS experience at the Walter and Eliza Hall Institute of Medical Research - eighteen million assays and countingKurt Lackovic, Guillaume Lessene, Hendrik Falk, et al.Angewandte Chemie (International Ed. in English)|September 30, 2017
Total Synthesis of (-)-SpiroleucettadineRichard A Lamb, Nicholas S Aberle, Nigel T Lucas, et al.Cancer Letters|March 17, 2006
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors)Yumiko Hirokawa, Alexander Levitzki, Guillaume Lessene, et al.Cancer Medicine|March 18, 2022
Dual drug targeting to kill colon cancersSilvia Paola Corona, Francesca Walker, Janet Weinstock, et al.Organic & Biomolecular Chemistry|June 1, 2012
Synthesis of conformationally constrained benzoylureas as BH3-mimeticsRyan M Brady, Effie Hatzis, Theresa Connor, et al.Cancer Cell|December 12, 2018
BH3-Mimetic Drugs: Blazing the Trail for New Cancer MedicinesDelphine Merino, Gemma L Kelly, Guillaume Lessene, et al.Nature Reviews. Cancer|October 19, 2021
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugsSarah T Diepstraten, Mary Ann Anderson, Peter E Czabotar, et al.Pageof 9